Taylor Wessing advises tech VC firm Dawn Capital on unicorn deal


23-01-2020

Taylor Wessing has advised early-stage tech investor Dawn Capital on its secondary purchase of shares from shareholders of Dataiku Inc. This values Dataiku at over USD1 billion.

This is the latest in a long line of deals that Taylor Wessing has advised Dawn Capital on. Earlier this January, Taylor Wessing also advised Dawn Capital on its participation in the EUR 90 million funding round for European open banking platform Tink. In November 2019, the firm advised Dawn Capital on its participation in the £29m Series B round for natural language processing company Eigen Technologies.

Commenting on the transactions, partner Howard Palmer, said: "Dawn Capital has an ethos of investing in the most cutting-edge, entrepreneur-led technology companies. This commitment to new technology is a value that we share and we're pleased that our expertise has contributed to these investments. In addition, it has been a pleasure to work with such a long-standing client on these funding rounds which all add to Dawn Capital's portfolio and allow the companies they are investing in to develop further."

Taylor Wessing fielded an international team on the secondary purchase of shares from shareholders of Dataiku Inc led by corporate partner Howard Palmer in the UK and corporate partner Nicolas de Witt with the support of corporate associate Alix Payraudeau, both in France.

The Taylor Wessing team worked in partnership with Wilson Sonsini Goodrich & Rosati (WSGR), whose team was led by partner Mike Labriola and included associate Elisa Sielski.

To read more information, click here.

Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private

Taylor Wessing